Is epilepsy a preventable disorder? New evidence from animal models

Neuroscientist

Volumn 16, Issue 3, 2010, Pages 253-275

  Giblin, Kathryn A ^a   Blumenfeld, Hal ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired epilepsy; Activity dependent; Animal models; Epileptogenesis; Idiopathic generalized epilepsy; Prevention

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ADENOSINE; AMPA RECEPTOR; CARBAMAZEPINE; CYCLOHEXIMIDE; ETHOSUXIMIDE; ETIRACETAM; GALANIN; GLUTAMATE RECEPTOR ANTAGONIST; MAGNESIUM; MAMMALIAN TARGET OF RAPAMYCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE Y; NEUROTROPHIN; NORADRENALIN; PHENOBARBITAL; PHENYTOIN; PROTEIN KINASE; PROTEIN KINASE M ZETA; RAPAMYCIN; SODIUM CHANNEL BLOCKING AGENT; TACROLIMUS; TALAMPANEL; TETRODOTOXIN; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; VOLTAGE GATED POTASSIUM CHANNEL;

BRAIN HYPOXIA; CELL LOSS; DRUG MECHANISM; DRUG TARGETING; DRUG TREATMENT FAILURE; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; EVIDENCE BASED PRACTICE; EXPERIMENTAL MODEL; FEBRILE CONVULSION; GENERALIZED EPILEPSY; HUMAN; KINDLING; MEDICAL RESEARCH; NERVE CELL EXCITABILITY; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TRAUMATIC BRAIN INJURY; TRAUMATIC EPILEPSY; TUBEROUS SCLEROSIS; WISTAR ALBINO GLAXO RAT;

ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY; EVIDENCE-BASED MEDICINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURAL CONDUCTION;

EID: 77952592440     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858409354385     Document Type: Review

References (180)

1. Adams B., Sazgar M., Osehobo P., Van der Zee CE, Diamond J., Fahnestock M., Racine RJ 1997. Nerve growth factor accelerates seizure development, enhances mossy fiber sprouting, and attenuates seizure-induced decreases in neuronal density in the kindling model of epilepsy. J Neurosci 17: 5288-5296.
2. Albertson TE, Joy RM, Stark LG 1984. A pharmacological study in the kindling model of epilepsy. Neuropharmacology 23: 1117-1123.
3. Andre V., Ferrandon A., Marescaux C., Nehlig A. 2000. Electroshocks delay seizures and subsequent epileptogenesis but do not prevent neuronal damage in the lithium-pilocarpine model of epilepsy. Epilepsy Res 42: 7-22.
4. Andre V., Ferrandon A., Marescaux C., Nehlig A. 2001. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 47: 99-117.
5. Andre V., Rigoulot MA, Koning E., Ferrandon A., Nehlig A. 2003. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia 44: 893-903.
6. Annegers JF, Hauser WA, Coan SP, Rocca WA 1998. A population-based study of seizures after traumatic brain injuries. N Engl J Med 338: 20-24.
7. Arshavsky YI 2009. Two functions of early language experience. Brain Res Rev 60: 327-340.
8. Aujla PK, Fetell MR, Jensen FE 2009. Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model. Epilepsia 50: 694-701.
9. Bains JS, Longacher JM, Staley KJ 1999. Reciprocal interactions between CA3 network activity and strength of recurrent collateral synapses. Nat Neurosci 2: 720-726.
10. Ben-Ari Y., Holmes GL 2006. Effects of seizures on developmental processes in the immature brain. Lancet Neurol 5: 1055-1063. (Pubitemid 44709981)
11. Bengzon J., Kokaia M., Brundin P., Lindvall O. 1990. Seizure suppression in kindling epilepsy by intrahippocampal locus coeruleus grafts: evidence for an alpha-2-adrenoreceptor mediated mechanism. Exp Brain Res 81: 433-437.
12. Binder DK, Routbort MJ, McNamara JO 1999 a. Immunohistochemical evidence of seizure-induced activation of trk receptors in the mossy fiber pathway of adult rat hippocampus. J Neurosci 19: 4616-4626.
13. Binder DK, Routbort MJ, Ryan TE, Yancopoulos GD, McNamara JO 1999 b. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J Neurosci 19: 1424-1436.
14. Blumenfeld H., McCormick DA 2000. Corticothalamic inputs control the pattern of activity generated in thalamocortical networks. J Neurosci 20: 5153-5162.
15. Blumenfeld H., Rivera M., Vasquez JG, Shah A., Ismail D., Enev M., Zaveri HP 2007. Neocortical and thalamic spread of amygdala kindled seizures. Epilepsia 48: 254-262.
16. Blumenfeld H., Klein JP, Schridde U., Vestal M., Rice T., Khera DS, and others. 2008. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 49 (3). 400-409.
17. Blumenfeld H., Lampert A., Klein JP, Mission J., Chen MC, Rivera M., and others. 2009. Role of hippocampal sodium channel Nav1.6 in kindling epileptogenesis. Epilepsia 50: 44-55.
18. Bolanos AR, Sarkisian M., Yang Y., Hori A., Helmers SL, Mikati M., and others. 1998. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 51: 41-48.
19. Bouilleret V., Hogan RE, Velakoulis D., Salzberg MR, Wang L., Egan GF, and others. 2009. Morphometric abnormalities and hyperanxiety in genetically epileptic rats: a model of psychiatric comorbidity? Neuroimage 45 (2). 267-274.
20. Bragin A., Wilson CL, Engel J. Jr. 2000. Chronic epileptogenesis requires development of a network of pathologically interconnected neuron clusters: a hypothesis. Epilepsia 41 (Suppl 6). S144-52.
21. Bragin A., Wilson CL, Almajano J., Mody I., Engel J. Jr. 2004. High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 45: 1017-1023.
22. Brandt C., Potschka H., Loscher W., Ebert U. 2003. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118: 727-740.
23. Brandt C., Gastens AM, Sun M., Hausknecht M., Loscher W. 2006. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 51: 789-804.
24. Brandt C., Glien M., Gastens AM, Fedrowitz M., Bethmann K., Volk HA, and others. 2007rophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 53: 207-221.
25. Brooks-Kayal AR, Raol YH, Russek SJ 2009. Alteration of epileptogenesis genes. Neurotherapeutics 6: 312-318.
26. Brooks-Kayal AR, Shumate MD, Jin H., Rikhter TY, Coulter DA 1998. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4: 1166-1172.
27. Cacheaux LP, Ivens S., David Y., Lakhter AJ, Bar-Klein G., Shapira M., and others. 2009. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci 29: 8927-8935.
28. Cain DP, Desborough KA, McKitrick DJ 1988. Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling. Exp Neurol 100: 179-187.
29. Carmichael ST, Chesselet MF 2002. Synchronous neuronal activity is a signal for axonal sprouting after cortical lesions in the adult. J Neurosci 22: 6062-6070.
30. Chahboune H., Mishra AM, DeSalvo MN, Staib LH, Purcaro M., Scheinost D., and others. 2009. DTI abnormalities in anterior corpus callosum of rats with spike-wave epilepsy. Neuroimage 47: 459-466.
31. Crino PB, Nathanson KL, Henske EP 2006. The tuberous sclerosis complex. N Engl J Med 355: 1345-1356.
32. DAmbrosio R., Fairbanks JP, Fender JS, Born DE, Doyle DL, Miller JW 2004ost-traumatic epilepsy following fluid percussion injury in the rat. Brain 127: 304-314.
33. Danzer SC, He X., McNamara JO 2004. Ontogeny of seizure-induced increases in BDNF immunoreactivity and TrkB receptor activation in rat hippocampus. Hippocampus 14: 345-355.
34. de Boer HM, Mula M., Sander JW 2008. The global burden and stigma of epilepsy. Epilepsy Behav 12: 540-546.
35. Depaulis A., van Luijtelaar EL 2005. Genetic models of absence epilepsy in the rat. In PitkàCurrency signnen A, Schwartzkroin PA, Mosche SL (eds) Models of seizures and epilepsy. Elsevier Academic Press, London: 233-248.
36. Diaz-Arrastia R., Agostini MA, Madden CJ, Van Ness PC 2009osttraumatic epilepsy: the endophenotypes of a human model of epileptogenesis. Epilepsia 50 (Suppl 2). 14-20.
37. Dichter MA 2009 a. Emerging concepts in the pathogenesis of epilepsy and epileptogenesis. Arch Neurol 66: 443-447.
38. Dichter MA 2009 bosttraumatic epilepsy: the challenge of translating discoveries in the laboratory to pathways to a cure. Epilepsia 50 (Suppl 2). 41-45.
39. Dube CM, Brewster AL, Baram TZ 2009. Febrile seizures: mechanisms and relationship to epilepsy. Brain & Development 31: 366-371.
40. Dudek FE, Bertram EH, Staley KJ 2008. Antiepileptogenesis therapy with levetiracetam: data from kindling versus status epilepticus models. Epilepsy Curr 8: 28-30.
41. Echlin FA, Battista A. 1963. Epileptiform seizures from chronic isolated cortex. Arch Neurol 9: 154-170.
42. Ehle AL 1980. Effects of phenytoin on amygdaloid kindled seizures in the rat. Electroencephalogr Clin Neurophysiol 48: 102-105.
43. Ellens DJ, Hong E., Giblin K., Singleton MJ, Bashyal C., Englot DJ, and others. 2009. Development of spike-wave seizures in C3H/HeJ mice. Epilepsy Research 85: 53-59.
44. Engel J. Jr, Bragin A., Staba R., Mody I. 2009. High-frequency oscillations: what is normal and what is not? Epilepsia 50: 598-604.
45. Erbayat-Altay E., Zeng LH, Xu L., Gutmann DH, Wong M. 2007. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis. Epilepsia 48: 1470-1476.
46. Esclapez M., Hirsch JC, Ben-Ari Y., Bernard C. 1999. Newly formed excitatory pathways provide a substrate for hyperexcitability in experimental temporal lobe epilepsy. J Comp Neurol 408: 449-460.
47. Forsgren L., Beghi E., Oun A., Sillanpaa M. 2005. The epidemiology of epilepsy in Europe: a systematic review. Eur J Neurol 12: 245-253.
48. Frey LC 2003. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 44 (Suppl 10). 11-17.
49. Friedman A., Kaufer D., Heinemann U. 2009. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 85: 142-149.
50. Fujikawa DG, Itabashi HH, Wu A., Shinmei SS 2000. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 41: 981-991.
51. Funabashi T., Sasaki H., Kimura F. 1988. Intraventricular injection of antiserum to nerve growth factor delays the development of amygdaloid kindling. Brain Res 458: 132-136.
52. Gao X., Zhang Y., Arrazola P., Hino O., Kobayashi T., Yeung RS, and others. 2002. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 4: 699-704.
53. Goddard GV, McIntyre DC, Leech CK 1969. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25: 295-330.
54. Graber KD, Prince DA 1999. Tetrodotoxin prevents posttraumatic epileptogenesis in rats. Ann Neurol 46: 234-242.
55. Graber KD, Prince DA 2004. A critical period for prevention of posttraumatic neocortical hyperexcitability in rats. Ann Neurol 55: 860-870.
56. Hanson MG, Landmesser LT 2004. Normal patterns of spontaneous activity are required for correct motor axon guidance and the expression of specific guidance molecules. Neuron 43: 687-701.
57. Hauser WA, Annegers JF 1991. Risk factors for epilepsy. Epilepsy Res Suppl 4: 45-52.
58. He XP, Minichiello L., Klein R., McNamara JO 2002. Immunohistochemical evidence of seizure-induced activation of trkB receptors in the mossy fiber pathway of adult mouse hippocampus. J Neurosci 22: 7502-7508.
59. He XP, Kotloski R., Nef S., Luikart BW, Parada LF, McNamara JO 2004. Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 43: 31-42.
60. Heida JG, Englot DJ, Sacktor TC, Blumenfeld H., Moshe SL 2009. Separating kindling and LTP: lessons from studies of PKM zeta in developing and adult rats. Neurosci Lett 453: 229-232.
61. Hellier JL, Patrylo PR, Dou P., Nett M., Rose GM, Dudek FE 1999. Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment. J Neurosci 19: 10053-10064.
62. Herman ST 2002. Epilepsy after brain insult: targeting epileptogenesis. Neurology 59: S21-6.
63. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. 2000. Major depression is a risk factor for seizures in older adults. Ann Neurol 47: 246-249.
64. Hesdorffer DC, Logroscino G., Cascino G., Annegers JF, Hauser WA 1998. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol 44: 908-912.
65. Hicks R., Soares H., Smith D., McIntosh T. 1996. Temporal and spatial characterization of neuronal injury following lateral fluid-percussion brain injury in the rat. Acta Neuropathol 91: 236-246.
66. Hicks RR, Martin VB, Zhang L., Seroogy KB 1999. Mild experimental brain injury differentially alters the expression of neurotrophin and neurotrophin receptor mRNAs in the hippocampus. Exp Neurol 160: 469-478.
67. Hill-Felberg SJ, McIntosh TK, Oliver DL, Raghupathi R., Barbarese E. 1999. Concurrent loss and proliferation of astrocytes following lateral fluid percussion brain injury in the adult rat. J Neurosci Res 57: 271-279.
68. Hoffman SN, Salin PA, Prince DA 1994. Chronic neocortical epileptogenesis in vitro. J Neurophysiol 71: 1762-1773.
69. Holt-Seitz A., Wirrell EC, Sundaram MB 1999. Seizures in the elderly: etiology and prognosis. Can J Neurol Sci 26: 110-114.
70. Horn G. 2004athways of the past: the imprint of memory. Nat Rev Neurosci 5: 108-120.
71. Huang YZ, Pan E., Xiong ZQ, McNamara JO 2008. Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron 57: 546-558.
72. Hunt RF, Scheff SW, Smith BN 2009osttraumatic epilepsy after controlled cortical impact injury in mice. Exp Neurol 215: 243-252.
73. Inoki K., Li Y., Zhu T., Wu J., Guan KL 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657.
74. Jansen LA, Uhlmann EJ, Crino PB, Gutmann DH, Wong M. 2005. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes. Epilepsia 46: 1871-1880.
75. Jensen FE 2006. Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr 18: 628-633.
76. Jensen FE, Blume H., Alvarado S., Firkusny I., Geary C. 1995. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia. Epilepsia 36: 966-972.
77. Jolkkonen J., Halonen T., Jolkkonen E., Nissinen J., Pitkanen A. 1996. Seizure-induced damage to the hippocampus is prevented by modulation of the GABAergic system. Neuroreport 7: 2031-2035.
78. Jung KH, Chu K., Kim M., Jeong SW, Song YM, Lee ST, and others. 2004. Continuous cytosine-b-D-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Eur J Neurosci 19: 3219-3226.
79. Jung S., Jones TD, Lugo JN Jr, Sheerin AH, Miller JW, DAmbrosio R., and others. 2007rogressive dendritic HCN channelopathy during epileptogenesis in the rat pilocarpine model of epilepsy. J Neurosci 27: 13012-13021.
80. Kanter-Schlifke I., Georgievska B., Kirik D., Kokaia M. 2007 a. Seizure suppression by GDNF gene therapy in animal models of epilepsy. Mol Ther 15: 1106-1113.
81. Kanter-Schlifke I., Toft Sorensen A., Ledri M., Kuteeva E., Hokfelt T., Kokaia M. 2007 b. Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity. Neuroscience 150: 984-992.
82. Karpova AV, Bikbaev AF, Coenen AM, van Luijtelaar G. 2005. Morphometric Golgi study of cortical locations in WAG/Rij rats: the cortical focus theory. Neurosci Res 51: 119-128.
83. Kelley MS, Jacobs MP, Lowenstein DH 2009. The NINDS epilepsy research benchmarks. Epilepsia 50: 579-582.
84. Kharatishvili I., Nissinen JP, McIntosh TK, Pitkanen A. 2006. A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 140: 685-697.
85. Kharatishvili I., Immonen R., Grohn O., Pitkanen A. 2007. Quantitative diffusion MRI of hippocampus as a surrogate marker for post-traumatic epileptogenesis. Brain 130: 3155-3168.
86. Kharatishvili I., Sierra A., Immonen RJ, Grohn OH, Pitkanen A. 2009. Quantitative T2 mapping as a potential marker for the initial assessment of the severity of damage after traumatic brain injury in rat. Exp Neurol 217: 154-164.
87. Kim JH, Im KC, Kim JS, Lee SA, Kang JK 2005. Correlation of interictal spike-wave with thalamic glucose metabolism in juvenile myoclonic epilepsy. Neuroreport 16: 1151-1155.
88. Klein JP, Khera DS, Nersesyan H., Kimchi EY, Waxman SG, Blumenfeld H. 2004. Dysregulation of sodium channel expression in cortical neurons in a rodent model of absence epilepsy. Brain Res 1000: 102-109.
89. Knudsen EI 2004. Sensitive periods in the development of the brain and behavior. J Cogn Neurosci 16: 1412-1425.
90. Kobayashi M., Buckmaster PS 2003. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23: 2440-2452.
91. Kodama M., Yamada N., Sato K., Kitamura Y., Koyama F., Sato T., and others. 1999. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat. Eur J Pharmacol 374: 11-19.
92. Koh S., Tibayan FD, Simpson JN, Jensen FE 2004. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45: 569-575.
93. Kojima N., Borlikova G., Sakamoto T., Yamada K., Ikeda T., Itohara S., and others. 2008. Inducible cAMP early repressor acts as a negative regulator for kindling epileptogenesis and long-term fear memory. J Neurosci 28: 6459-6472.
94. Kokaia M., Ernfors P., Kokaia Z., Elmer E., Jaenisch R., Lindvall O. 1995. Suppressed epileptogenesis in BDNF mutant mice. Experimental Neurology 133: 215-224.
95. Kumar SS, Buckmaster PS 2006. Hyperexcitability, interneurons, and loss of GABAergic synapses in entorhinal cortex in a model of temporal lobe epilepsy. J Neurosci 26: 4613-4623.
96. la Fougere C., Rominger A., Forster S., Geisler J., Bartenstein P. 2009ET and SPECT in epilepsy: a critical review. Epilepsy Behav 15: 50-55.
97. Larmet Y., Reibel S., Carnahan J., Nawa H., Marescaux C., Depaulis A. 1995rotective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport 6: 1937-1941.
98. Lemos T., Cavalheiro EA 1995. Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp Brain Res 102: 423-428.
99. Lighthall JW 1988. Controlled cortical impact: a new experimental brain injury model. J Neurotrauma 5: 1-15.
100. Lin K., Carrete H. Jr, Lin J., Peruchi MM, de Araujo Filho GM, Guaranha MS, and others. 2009. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy. Epilepsia 50: 1191-1200.
101. Lindvall O., Bengzon J., Brundin P., Kalen P., Kokaia M. 1990. Locus coeruleus grafts in hippocampal kindling epilepsy: noradrenaline release, receptor specificity and influence on seizure developmentrog Brain Res 82: 339-346.
102. Liu DS, OBrien TJ, Williams DA, Hicks RJ, Myers DE 2009. Lamina-specific changes in hippocampal GABA(A)/cBZR and mossy fibre sprouting during and following amygdala kindling in the rat. Neurobiol Dis 35: 337-347.
103. Longo BM, Mello LE 1997. Blockade of pilocarpine- or kainate-induced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci Lett 226: 163-166.
104. Loscher W. 2002. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs: a comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50: 105-123.
105. Loscher W., Honack D., Rundfeldt C. 1998. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 284: 474-479.
106. Lowenstein DH 2009. Epilepsy after head injury: an overview. Epilepsia 50 (Suppl 2). 4-9.
107. Luat AF, Chugani HT 2008. Molecular and diffusion tensor imaging of epileptic networks. Epilepsia 49 (Suppl 3). 15-22.
108. Margineanu DG, Matagne A., Kaminski RM, Klitgaard H. 2008. Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats. Brain Res Bull. Aug 20 [Epub ahead of print].
109. Martin MS, Tang B., Papale LA, Yu FH, Catterall WA, Escayg A. 2007. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Hum Mol Genet 16: 2892-2899.
110. Massa R., de Saint-Martin A., Carcangiu R., Rudolf G., Seegmuller C., Kleitz C., and others. 2001. EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology 57: 1071-1079.
111. Matsumoto H., Marsan CA 1964. Cortical cellular phenomena in experimental epilepsy: ictal manifestations. Exp Neurol 9: 305-326.
112. McIntosh TK, Vink R., Noble L., Yamakami I., Fernyak S., Soares H., Faden AL 1989. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 28: 233-244. (Pubitemid 19026758)
113. McNamara JO, Huang YZ, Leonard AS 2006. Molecular signaling mechanisms underlying epileptogenesis. Sci STKE 2006: re12.
114. Meeren HK, Pijn JP, Van Luijtelaar EL, Coenen AM, Lopes da Silva FH 2002. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 22: 1480-1495.
115. Mhyre TR, Applegate CD 2003ersistent regional increases in brain-derived neurotrophic factor in the flurothyl model of epileptogenesis are dependent upon the kindling status of the animal. Neuroscience 121: 1031-1045.
116. Muller-Schwarze AB, Tandon P., Liu Z., Yang Y., Holmes GL, Stafstrom CE 1999. Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport 10: 1517-1522.
117. Muncy J., Butler IJ, Koenig MK 2009. Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol 24: 477.
118. Nicolai J., van der Linden I., Arends JB, van Mil SG, Weber JW, Vles JS, Aldenkamp AP 2007. EEG characteristics related to educational impairments in children with benign childhood epilepsy with centrotemporal spikes. Epilepsia 48: 2093-2100.
119. Niquet J., Liu H., Wasterlain CG 2005rogrammed neuronal necrosis and status epilepticus. Epilepsia 46 (Suppl 5). 43-48.
120. Nishida M., Juhasz C., Sood S., Chugani HT, Asano E. 2008. Cortical glucose metabolism positively correlates with gamma-oscillations in nonlesional focal epilepsy. Neuroimage 42: 1275-1284.
121. Noe F., Pool AH, Nissinen J., Gobbi M., Bland R., Rizzi M., and others. 2008. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 131: 1506-1515.
122. OBrien RJ, Xu D., Petralia RS, Steward O., Huganir RL, Worley P. 1999. Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp. Neuron 23: 309-323.
123. Perez Y., Morin F., Beaulieu C., Lacaille JC 1996. Axonal sprouting of CA1 pyramidal cells in hyperexcitable hippocampal slices of kainate-treated rats. Eur J Neurosci 8: 736-748.
124. Pitkanen A., Immonen RJ, Grohn OH, Kharatishvili I. 2009. From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options. Epilepsia 50 (Suppl 2). 21-29.
125. Post RM, Weiss SR, Pert A. 1984. Differential effects of carbamazepine and lithium on sensitization and kindlingrog Neuropsychopharmacol Biol Psychiatry 8: 425-434.
126. Prince DA 1968. The depolarization shift in "epileptic" neurons. Exp Neurol 21: 467-485.
127. Prince DA, Parada I., Scalise K., Graber K., Jin X., Shen F. 2009. Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis. Epilepsia 50 (Suppl 2). 30-40.
128. Racine RJ 1972. Modification of seizure activity by electrical stimulation. II: motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.
129. Rakhade SN, Shah AK, Agarwal R., Yao B., Asano E., Loeb JA 2007. Activity-dependent gene expression correlates with interictal spiking in human neocortical epilepsy. Epilepsia 48 (Suppl 5). 86-95.
130. Rakhade SN, Zhou C., Aujla PK, Fishman R., Sucher NJ, Jensen FE 2008. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J Neurosci 28: 7979-7990.
131. Ransom CB, Blumenfeld H. 2007. Acquired epilepsy: cellular and molecular mechanisms. In: Waxman SG, editor. Molecular neurology. Burlington (MA): Elsevier Academic Press 347-370.
132. Rao MS, Hattiangady B., Reddy DS, Shetty AK 2006. Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy. J Neurosci Res 83: 1088-1105.
133. Raol YH, Lund IV, Bandyopadhyay S., Zhang G., Roberts DS, Wolfe JH, and others. 2006. Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 26: 11342-11346.
134. Richichi C., Brewster AL, Bender RA, Simeone TA, Zha Q., Yin HZ, and others. 2008. Mechanisms of seizure-induced transcriptional channelopathy of hyperpolarization-activated cyclic nucleotide gated (HCN) channels. Neurobiol Dis 29: 297-305.
135. Rogawski MA, Kurzman PS, Yamaguchi SI, Li H. 2001. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse. Neuropharmacology 40: 28-35.
136. Salin P., Tseng GF, Hoffman S., Parada I., Prince DA 1995. Axonal sprouting in layer V pyramidal neurons of chronically injured cerebral cortex. J Neurosci 15: 8234-8245.
137. Sanchez RM, Dai W., Levada RE, Lippman JJ, Jensen FE 2005. AMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brain. J Neurosci 25: 3442-3451.
138. Sanchez RM, Koh S., Rio C., Wang C., Lamperti ED, Sharma D., and others. 2001. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 21: 8154-8163.
139. Sander JW 2003. The epidemiology of epilepsy revisited. Curr Opin Neurol 16: 165-170.
140. Sarkisova KY, Kuznetsova GD, Kulikov MA, van Luijtelaar G. 2009. Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia. Aug 8. [Epub ahead of print].
141. Sato K., Morimoto K., Okamoto M. 1988. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Brain Res 463: 12-20.
142. Sato K., Kashihara K., Morimoto K., Hayabara T. 1996. Regional increases in brain-derived neurotrophic factor and nerve growth factor mRNAs during amygdaloid kindling, but not in acidic and basist growth factor mRNAs. Epilepsia 37: 6-14.
143. Savic I., Osterman Y., Helms G. 2004. MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies. Neuroimage 21: 163-172.
144. Scharfman HE 1997. Hyperexcitability in combined entorhinal/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor. J Neurophysiol 78: 1082-1095.
145. Schierhout G., Roberts I. 2001. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev CD000173.
146. Schridde U., van Luijtelaar G. 2004. The influence of strain and housing on two types of spike-wave discharges in rats. Genes Brain Behav 3: 1-7.
147. Schridde U., Strauss U., Brauer AU, van Luijtelaar G. 2006. Environmental manipulations early in development alter seizure activity, Ih and HCN1 protein expression later in life. Eur J Neurosci 23: 3346-3358.
148. Schubert M., Siegmund H., Pape HC, Albrecht D. 2005. Kindling-induced changes in plasticity of the rat amygdala and hippocampus. Learn Mem 12: 520-526.
149. Shema R., Sacktor TC, Dudai Y. 2007. Rapid erasure of long-term memory associations in the cortex by an inhibitor of PKM zeta. Science 317: 951-953.
150. Shin C., Rigsbee LC, McNamara JO 1986. Anti-seizure and anti-epileptogenic effect of gamma-vinyl gamma-aminobutyric acid in amygdaloid kindling. Brain Res 398: 370-374.
151. Shinnar S, Berg AT, ODell C, Newstein D, Moshe SL, Hauser WA. 2000redictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol 48: 140-147.
152. Silverstein FS, Jensen FE 2007. Neonatal seizures. Ann Neurol 62: 112-120.
153. Sloviter RS 1987. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235: 73-76.
154. Song G., Dhodda VK, Blei AT, Dempsey RJ, Rao VL 2002. GeneChip analysis shows altered mRNA expression of transcripts of neurotransmitter and signal transduction pathways in the cerebral cortex of portacaval shunted rats. J Neurosci Res 68: 730-737.
155. Staley K., Hellier JL, Dudek FE 2005. Do interictal spikes drive epileptogenesis ? Neuroscientist 11: 272-276.
156. Staley KJ, Dudek FE 2006. Interictal spikes and epileptogenesis. Epilepsy Curr 6 (6). 199-202.
157. Strauss U., Kole MH, Brauer AU, Pahnke J., Bajorat R., Rolfs A., and others. 2004. An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy. Eur J Neurosci 19: 3048-3058.
158. Sundaram M., Sadler RM, Young GB, Pillay N. 1999. EEG in epilepsy: current perspectives. Can J Neurol Sci 26: 255-262.
159. Sutula TP, Dudek FE 2007. Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: an emergent property of a complex systemrog Brain Res 163: 541-563.
160. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. 2002. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signalingroc Natl Acad Sci U S A 99: 13571-13576.
161. Temkin NR 2009reventing and treating posttraumatic seizures: the human experience. Epilepsia 50 (Suppl 2). 10-13.
162. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J., Chabal S., Winn HR 1990. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 323: 497-502.
163. Tsui CC, Copeland NG, Gilbert DJ, Jenkins NA, Barnes C., Worley PF 1996. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J Neurosci 16: 2463-2478.
164. Uhlmann EJ, Wong M., Baldwin RL, Bajenaru ML, Onda H., Kwiatkowski DJ, and others. 2002. Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 52: 285-296.
165. Urbach H. 2005. Imaging of the epilepsies. Eur Radiol 15: 494-500.
166. Van der Zee CE, Rashid K., Le K., Moore KA, Stanisz J., Diamond J., and others. 1995. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J Neurosci 15: 5316-5323.
167. van Vliet EA, da Costa Araujo S., Redeker S., van Schaik R., Aronica E., Gorter JA 2007. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130: 521-534.
168. Vezzani A., Balosso S., Ravizza T. 2008. The role of cytokines in the pathophysiology of epilepsy. Brain, Behavior, & Immunity 22: 797-803.
169. Weiss SR, Post RM 1987. Carbamazepine and carbamazepine-10,11-epoxide inhibit amygdala-kindled seizures in the rat but do not block their development. Clin Neuropharmacol 10: 272-279.
170. White HS 2002. Animal models of epileptogenesis. Neurology 59: S7 - S14.
171. Wiesel TN, Hubel DH 1965. Extent of recovery from the effects of visual deprivation in kittens. J Neurophysiol 28: 1060-1072.
172. Williams PA, Wuarin JP, Dou P., Ferraro DJ, Dudek FE 2002. Reassessment of the effects of cycloheximide on mossy fiber sprouting and epileptogenesis in the pilocarpine model of temporal lobe epilepsy. J Neurophysiol 88: 2075-2087.
173. Williams PA, White AM, Clark S., Ferraro DJ, Swiercz W., Staley KJ, Dudek FE 2009. Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J Neurosci 29: 2103-2112.
174. Wilz A., Pritchard EM, Li T., Lan JQ, Kaplan DL, Boison D. 2008. Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials 29: 3609-3616.
175. Wuarin JP, Dudek FE 1996. Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J Neurosci 16: 4438-4448.
176. Yang J., Houk B., Shah J., Hauser KF, Luo Y., Smith G., and others. 2005. Genetic background regulates semaphorin gene expression and epileptogenesis in mouse brain after kainic acid status epilepticus. Neuroscience 131: 853-869.
177. Zeng LH, Rensing NR, Wong M. 2009. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29: 6964-6972.
178. Zeng LH, Xu L., Gutmann DH, Wong M. 2008. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63: 444-453.
179. Zeng LH, Ouyang Y., Gazit V., Cirrito JR, Jansen LA, Ess KC, and others. 2007. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol Dis 28: 184-196.
180. Zhang N., Wei W., Mody I., Houser CR 2007. Altered localization of GABA(A) receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci 27: 7520-7531.